Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use
Cell Stem Cell · 2025-06 · 32 (6) · 878-894
DOI: 10.1016/j.stem.2025.05.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Stem Cell, 2025-06. Verfasst von Sowmya Viswanathan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Schroeder Arthritis Institute, University Health Network, Toronto, ON M5T 0S8, Canada; Krembil Research Institute, University Health Network, Toronto…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 184 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Schroeder Arthritis Institute, University Health Network, Toronto, ON M5T 0S8, Canada; Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada; Institute of Biomedical Engineering, University…
- Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI 53705, USA. Electronic address: jgalipeau@wisc.edu.
Zitieren
APA
Viswanathan, S., & Galipeau, J. (2025). Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use. Cell Stem Cell, 32(6), 878-894. https://doi.org/10.1016/j.stem.2025.05.008
Vancouver
Viswanathan S, Galipeau J. Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use. Cell Stem Cell. 2025;32(6):878-894. doi:10.1016/j.stem.2025.05.008
BibTeX
@article{Viswanathan2025,
author = {Viswanathan, Sowmya and Galipeau, Jacques},
title = {Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use},
journal = {Cell Stem Cell},
year = {2025},
volume = {32},
number = {6},
pages = {878--894},
doi = {10.1016/j.stem.2025.05.008}
}
EUVIMED